DIPLOMAT PHARMACY INC's ticker is DPLO and the CUSIP is 25456K101. A total of 139 filers reported holding DIPLOMAT PHARMACY INC in Q3 2019. The put-call ratio across all filers is 0.06 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $389,000 | +41.5% | 97,328 | +73.6% | 0.00% | – |
| Q3 2019 | $275,000 | +7.0% | 56,064 | +32.9% | 0.00% | – |
| Q2 2019 | $257,000 | +5.8% | 42,178 | +0.8% | 0.00% | – |
| Q1 2019 | $243,000 | -55.8% | 41,830 | +2.4% | 0.00% | -100.0% |
| Q4 2018 | $550,000 | -12.8% | 40,850 | +25.6% | 0.00% | 0.0% |
| Q3 2018 | $631,000 | -73.3% | 32,529 | -64.9% | 0.00% | -50.0% |
| Q2 2018 | $2,366,000 | +18.2% | 92,556 | -6.9% | 0.00% | 0.0% |
| Q1 2018 | $2,002,000 | +40.1% | 99,401 | +39.6% | 0.00% | +100.0% |
| Q4 2017 | $1,429,000 | +38.5% | 71,181 | +42.8% | 0.00% | 0.0% |
| Q3 2017 | $1,032,000 | +179.7% | 49,846 | +99.7% | 0.00% | – |
| Q2 2017 | $369,000 | -54.4% | 24,959 | -50.9% | 0.00% | -100.0% |
| Q1 2017 | $810,000 | -17.3% | 50,786 | -34.7% | 0.00% | 0.0% |
| Q4 2016 | $980,000 | -11.6% | 77,813 | +96.6% | 0.00% | 0.0% |
| Q3 2016 | $1,108,000 | -32.4% | 39,576 | -15.4% | 0.00% | -50.0% |
| Q2 2016 | $1,638,000 | +69.4% | 46,796 | +32.6% | 0.00% | +100.0% |
| Q1 2016 | $967,000 | -11.1% | 35,289 | +11.0% | 0.00% | 0.0% |
| Q4 2015 | $1,088,000 | +7.8% | 31,796 | -9.4% | 0.00% | 0.0% |
| Q3 2015 | $1,009,000 | -40.8% | 35,105 | -7.8% | 0.00% | -50.0% |
| Q2 2015 | $1,703,000 | +345.8% | 38,072 | +245.0% | 0.00% | – |
| Q1 2015 | $382,000 | +8.5% | 11,035 | -14.1% | 0.00% | – |
| Q4 2014 | $352,000 | – | 12,849 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|